MIM
NARI

Monashee Investment Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Monashee Investment Management’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,000
Closed -$2.27M – 49
2022
Q1 		$2.27M Buy
+25,000
New +$2.05M 0.66% 17

Other funds holding NARI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Monashee Investment Management's NARI Position: Q2 2022 in Review

Monashee Investment Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2022, closing a stake of 25,000 shares — an estimated $2.27M sold.

Monashee Investment Management first reported a position in NARI in Q1 2022 and held it in 1 quarter. The position peaked at $2.27M in Q1 2022. 227 funds tracked by Wall St. Rank hold NARI as of Q2 2022.

  • Monashee Investment Management reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Monashee Investment Management sold 25,000 Inari Medical, Inc. Common Stock shares in Q2 2022, an estimated $2.27M.
  • Monashee Investment Management first reported a position in Inari Medical, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Monashee Investment Management's Inari Medical, Inc. Common Stock position peaked at $2.27M in Q1 2022.
  • 227 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2022.

Based on Monashee Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.